Skip to main content
GL
NYSE Finance

Globe Life 10-Q: Q3 Net Income $361.1M, Diluted EPS $4.62, $120.5M Reserve Gain

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$161.72
Mkt Cap
$12.428B
52W Low
$129.21
52W High
$191.55
52W Position info
25% above low
Off High info
16% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

GL sits 25% above its 52-week low of $129.21.

Summary

Globe Life's Q3 10-Q shows net income of $361.1 million, or $4.62 per diluted share, helped by a $120.5 million pretax reserve gain, with health margins squeezed by Evry Health losses.


Key Events · Earnings and Guidance · GL

  • Q3 Net Income $361.1M, EPS $4.62

    Third-quarter revenue was $1.60 billion and net income $361.1 million, or $4.62 per diluted share, versus $4.73 a year earlier. For the nine months, net income was $919.4 million, or $11.64 per diluted share.

  • $120.5M Reserve Remeasurement Gain

    The annual assumption review produced a $120.5 million pretax net remeasurement gain ($96.4 million life, $24.1 million health), down from $134.3 million in the year-ago quarter, so the year-over-year profit decline partly reflects a smaller actuarial tailwind.

  • Health Margin Squeezed by Evry

    Health underwriting margin rose to $309.4 million from $291.2 million, but United American's margin fell to 2% from 6% as Evry Health claims drove a $26 million underwriting loss; management warns of continued volatility as Evry scales.

  • Buybacks and 22% Dividend Increase

    Globe Life repurchased 3.6 million shares for $564 million at an average $155.30 in the first nine months, with $2.4 billion remaining under the authorization, and raised the quarterly dividend 22% to $0.33 per share.


Analysis · GL · Finance

The headline numbers were already out on October 21, but this 10-Q is where the detail lives. Profit for the quarter leaned on a $120.5 million pretax reserve remeasurement gain from the annual assumption review, down from $134.3 million a year ago, so the underlying underwriting trend is softer than the headline suggests. Health is the pressure point: United American's underwriting margin fell to 2% from 6% as Evry Health's group medical business ran a $26 million underwriting loss, and management flags continued volatility there. Against that, life premium grew 3% and health premium 15%, book value per share rose 23% to $85.35, and the company bought back 3.6 million shares for $564 million while raising the dividend 22% to $0.33.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GL was trading at $161.72 on NYSE in the Finance sector, with a market capitalization of approximately $12.4B. The 52-week trading range was $129.21 to $191.55. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GL - Latest Insights

GL
Oct 21, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $169.62
Real-time Price: $151.65 info
Change: -$17.97 (-11%) info
Market Cap: $11.443B info
GL
Oct 21, 2026, 4:10 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $169.62
Real-time Price: $151.65 info
Change: -$17.97 (-11%) info
Market Cap: $11.443B info
GL
Aug 10, 2026, 9:43 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $187.96
Real-time Price: $151.65 info
Change: -$36.31 (-19%) info
Market Cap: $11.443B info
GL
Aug 05, 2026, 1:25 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $182.88
Real-time Price: $151.65 info
Change: -$31.23 (-17%) info
Market Cap: $11.443B info
GL
Aug 03, 2026, 5:08 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $184.09
Real-time Price: $151.65 info
Change: -$32.44 (-18%) info
Market Cap: $11.443B info